Functional Pathologies of the Musculoskeletal System in Physiotherapy Students (FUNPAMUS)

January 19, 2026 updated by: Kamila Řasová, Charles University, Czech Republic

Occurrence and Characteristics of Functional Pathologies of the Musculoskeletal System in Physiotherapy Students and the Possibility of Influencing Them

This study map the occurrence of functional pathologies of the musculoskeletal system in students of the bachelor's program of physiotherapy of the Third Faculty of Medicine, Charles University, and aim on improvement of them.

Study Overview

Status

Completed

Detailed Description

The aim of this study is to map the occurrence of functional pathologies of the musculoskeletal system in students of the bachelor's program of physiotherapy of the Third Faculty of Medicine, Charles University, and to examine their postural functions. Another goal is to teach the students of the experimental group how to remove functional pathologies of the musculoskeletal system and how to change their motor behaviour and postural functions so that the development of functional disorders no longer occurs.

Study Type

Interventional

Enrollment (Actual)

44

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Prague, Czechia
        • Department of rehabilitation, Third Faculty of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 26 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Bachelor's study of physiotherapy at the Third Faculty of Medicine, Charles University
  • The presence of functional pathologies of the musculoskeletal system (verification by means of Trigger Points)

Exclusion Criteria:

  • Serious cardiovascular or orthopedic dysfunction
  • Neurological disease
  • Reduced cognitive functions complicating examination and subsequent therapy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: individual outpatient physiotherapy
individual outpatient physiotherapy (7 times in two and a half months, approx. 90 minutes) aimed at correcting functional pathologies of the musculoskeletal system assessed by differential diagnosis (removal of trigger points, stretching of shortened muscles and mobilization of joint blockages) and changing of motor program that led to the occurrence of the functional disorder by means of Motor Programmes Activating Therapy
Physiotherapy aimed at correcting functional pathologies of the musculoskeletal system assessed by differential diagnosis (removal of trigger points, stretching of shortened muscles and mobilization of joint blockages)
Active Comparator: Without changing the current habits
It will not change the existing habits. At the same time, however, these are physiotherapy students who will participate in the classes. Their motor behaviour can thus be influenced in a natural way.
Physiotherapy aimed at correcting functional pathologies of the musculoskeletal system assessed by differential diagnosis (removal of trigger points, stretching of shortened muscles and mobilization of joint blockages)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Trigger Points at 3 months
Time Frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three months).
Local hypertonic change in muscle function arising as a manifestation of pathogenic tension, 0 no trigger point, 2 maximal tiger point (higher value, worse function)
Pre-assessment (baseline testing), Post-assessment (immediately after the end of three months).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in the Foot posture index at 3 and 15 month
Time Frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three months), Follow up (at 15 months).
Clinical examination of the foot type ranging from significantly pronated (values 6 - 12) to significantly supinated (values from -1 to -12) one according to the 6-item, higher value (both negative or positive) means worse function.
Pre-assessment (baseline testing), Post-assessment (immediately after the end of three months), Follow up (at 15 months).
Change in Foot morphology and flexibility at 3 and 15 month
Time Frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three months), Follow up (at 15 months).
examination by means of the full foot 3D scanner Footscan® and the software 3D scanner 7.7 while sitting and standing still. Arch high index defines two kinds of pathologies: hypermobility under 0,6, norm 0,7 - 0,8, rigidity 0,9 - 1,3
Pre-assessment (baseline testing), Post-assessment (immediately after the end of three months), Follow up (at 15 months).
Change in Postural stability at 3 and 15 month
Time Frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three months), Follow up (at 15 months).
evaluation of the level of postural stability using the total path of displacement of the centre of pressure of the body on the mat in mm and the maximum displacement obtained in the latero-lateral and in the anteroposterior direction in mm (lower number means better function), measurement using the RS Footscan® tensiometric plate, higher value means worse function.
Pre-assessment (baseline testing), Post-assessment (immediately after the end of three months), Follow up (at 15 months).
Change in the subtalar joint flexibility at 3 and 15 month
Time Frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three months), Follow up (at 15 months).
mobility of the subtalar joint during the initial phase of walking (software evaluation after walking barefoot on the Footscan® tensiometric plate). Under 5.5° means normal range of pronation and normal function. Higher values mean worse function and pathologic pronation during initial phase of gait.
Pre-assessment (baseline testing), Post-assessment (immediately after the end of three months), Follow up (at 15 months).
Change in the foot progression angle at 3 and 15 month
Time Frame: Pre-assessment (baseline testing), Post-assessment (immediately after the end of three months), Follow up (at 15 months).
rotation of the foot during walking (software evaluation after walking barefoot on the Footscan® tensiometric plate). Normal angle 0-5.4°, in-toeing (inwards rotation) under 0°, out-toeing (outward rotation) above 5.5°.
Pre-assessment (baseline testing), Post-assessment (immediately after the end of three months), Follow up (at 15 months).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kamila Rasova, Third Faculty of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2022

Primary Completion (Actual)

May 30, 2025

Study Completion (Actual)

May 30, 2025

Study Registration Dates

First Submitted

September 14, 2022

First Submitted That Met QC Criteria

September 14, 2022

First Posted (Actual)

September 16, 2022

Study Record Updates

Last Update Posted (Actual)

January 21, 2026

Last Update Submitted That Met QC Criteria

January 19, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe